HLA typing market on moderate growth path

The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.2 billion in 2019, at a CAGR of 5.9 percent, according to MarketsandMarkets. Growth in the HLA typing market is mainly driven by factors like the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research. However, the high costs of HLA typing products and limited reimbursements for target procedures are expected to restrain the market growth in the coming years. Along with this, the significant demand and supply gap between the number of organ donors and organs required annually is expected to challenge the market growth to a certain extent. The reagents and consumables segment accounted for the largest share of the HLA typing market in 2019. Factors like the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets are driving the growth of this segment.

The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019. The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis. The Asia-Pacific market is estimated to grow at the highest CAGR over the next 5 years, primarily with the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage in several Asia-Pacific countries.